Anchiano Therapeutics Ltd.

/Anchiano Therapeutics Ltd.

We are a clinical-stage biotechnology company committed to engineering a targeted gene therapy to improve the standard treatment for early-stage bladder cancer, which is one of the most prevalent forms of cancer.


Price Range
$14.55 - $14.55

Final Shares

Effective Date
February 12, 2019


To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange